Contract
Biomanufacturing Services Market
Contract Biomanufacturing Services Market Scope:
Request Sample Report
Contract Biomanufacturing Services Market Size and Growth
The Contract Biomanufacturing Services market is experiencing robust growth, driven by increasing demand for biologics and personalized medicine. Valued at approximately $10 billion in 2023, the market is projected to expand significantly due to advancements in technology, regulatory support, and a rise in outsourcing among pharmaceutical companies. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Abzena
◍ Albany Molecular
◍ Boehringer Ingelheim
◍ Catalent
◍ Charles River
◍ Fujifilm
◍ Horizon
◍ Innovent Biologics
◍ Jhl Biotech
◍ Lonza
◍ Merck
The Contract Biomanufacturing Services Market features key players like Lonza, Boehringer Ingelheim, and Catalent, offering expertise in biologics production to accelerate drug development. Companies leverage partnerships to enhance capabilities, reduce costs, and increase manufacturing efficiency. For example, Lonza reported approximately $5 billion in sales revenue, supporting market growth.
Request Sample Report
Market Segmentation
By Application
Clinical Laboratory
Medical Company
Other
Request Sample Report
By Product
Cooperative Manufacturing
Outsourcing
Market Growth
Request Sample Report
$ X Billion USD
